These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8032946)

  • 1. Methylprednisolone attenuates inflammation, increase of brain water content and intracranial pressure, but does not influence cerebral blood flow changes in experimental pneumococcal meningitis.
    Koedel U; Pfister HW; Tomasz A
    Brain Res; 1994 Apr; 644(1):25-31. PubMed ID: 8032946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats.
    Pfister HW; Koedel U; Lorenzl S; Tomasz A
    Stroke; 1992 Dec; 23(12):1798-804. PubMed ID: 1448831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis.
    Koedel U; Bernatowicz A; Frei K; Fontana A; Pfister HW
    J Immunol; 1996 Dec; 157(11):5185-91. PubMed ID: 8943431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis.
    Lorenzl S; Koedel U; Frei K; Bernatowicz A; Fontana A; Pfister HW
    J Infect Dis; 1995 Jul; 172(1):113-8. PubMed ID: 7797900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of catalase on regional cerebral blood flow and brain edema during the early phase of experimental pneumococcal meningitis.
    Pfister HW; Ködel U; Dirnagl U; Haberl RL; Ruckdeschel G; Einhäupl KM
    J Infect Dis; 1992 Dec; 166(6):1442-5. PubMed ID: 1431262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide.
    Koedel U; Bernatowicz A; Paul R; Frei K; Fontana A; Pfister HW
    Ann Neurol; 1995 Mar; 37(3):313-23. PubMed ID: 7535035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat.
    Lorenzl S; Koedel U; Pfister HW
    Crit Care Med; 1996 Nov; 24(11):1874-80. PubMed ID: 8917039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the bradykinin B2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat.
    Lorenzl S; Ködel U; Frei K; Pfister HW
    Eur J Pharmacol; 1996 Jul; 308(3):335-41. PubMed ID: 8858309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis.
    Pfister HW; Frei K; Ottnad B; Koedel U; Tomasz A; Fontana A
    J Exp Med; 1992 Jul; 176(1):265-8. PubMed ID: 1613460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor alpha induces only minor inflammatory changes in the central nervous system, but augments experimental meningitis.
    Angstwurm K; Freyer D; Dirnagl U; Hanisch UK; Schumann RR; Einhäupl KM; Weber JR
    Neuroscience; 1998 Sep; 86(2):627-34. PubMed ID: 9881875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats.
    Angstwurm K; Weber JR; Segert A; Bürger W; Weih M; Freyer D; Einhäupl KM; Dirnagl U
    Neurosci Lett; 1995 May; 191(1-2):1-4. PubMed ID: 7659273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis?
    Haberl RL; Anneser F; Ködel U; Pfister HW
    Neurol Res; 1994 Apr; 16(2):108-12. PubMed ID: 7913993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti ICAM-1 (CD 54) monoclonal antibody reduces inflammatory changes in experimental bacterial meningitis.
    Weber JR; Angstwurm K; Bürger W; Einhäupl KM; Dirnagl U
    J Neuroimmunol; 1995 Dec; 63(1):63-8. PubMed ID: 8557826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin B receptor-mediated increase of cerebral blood flow in experimental pneumococcal meningitis.
    Koedel U; Lorenzl S; Gorriz C; Arendt RM; Pfister HW
    J Cereb Blood Flow Metab; 1998 Jan; 18(1):67-74. PubMed ID: 9428307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular changes during the early phase of experimental bacterial meningitis.
    Pfister HW; Koedel U; Haberl RL; Dirnagl U; Feiden W; Ruckdeschel G; Einhäupl KM
    J Cereb Blood Flow Metab; 1990 Nov; 10(6):914-22. PubMed ID: 2211884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide dismutase inhibits brain oedema formation in experimental pneumococcal meningitis.
    Pfister HW; Koedel U; Dirnagl U; Haberl RL; Feiden W; Einhäupl KM
    Acta Neurochir Suppl (Wien); 1990; 51():378-80. PubMed ID: 2089945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis.
    Täuber MG; Khayam-Bashi H; Sande MA
    J Infect Dis; 1985 Mar; 151(3):528-34. PubMed ID: 3973406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial hydrogen peroxide contributes to cerebral hyperemia during early stages of experimental pneumococcal meningitis.
    Hoffmann OM; Becker D; Weber JR
    J Cereb Blood Flow Metab; 2007 Nov; 27(11):1792-7. PubMed ID: 17311075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced hypothermia in experimental pneumococcal meningitis.
    Angstwurm K; Reuss S; Freyer D; Arnold G; Dirnagl U; Schumann RR; Weber JR
    J Cereb Blood Flow Metab; 2000 May; 20(5):834-8. PubMed ID: 10826534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis.
    Kastenbauer S; Koedel U; Pfister HW
    J Infect Dis; 1999 Oct; 180(4):1164-70. PubMed ID: 10479144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.